Literature DB >> 31857048

No Association Between CHADS-VASc Score and Left Atrial Appendage Thrombus in Patients With Transthyretin Amyloidosis.

Eoin Donnellan, Mohamed B Elshazly, Sneha Vakamudi, Oussama M Wazni, Joshua A Cohen, Mohamed Kanj, Mazen Hanna, Bryan Baranowski, Walid Saliba, Wael Jaber.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31857048     DOI： 10.1016/j.jacep.2019.10.013

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN： 2405-500X


× No keyword cloud information.
  9 in total

1.  Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis - 2021.

Authors:  Marcus V Simões; Fabio Fernandes; Fabiana G Marcondes-Braga; Philip Scheinberg; Edileide de Barros Correia; Luis Eduardo P Rohde; Fernando Bacal; Silvia Marinho Martins Alves; Sandrigo Mangini; Andréia Biolo; Luis Beck-da-Silva; Roberta Shcolnik Szor; Wilson Marques Junior; Acary Souza Bulle Oliveira; Márcia Waddington Cruz; Bruno Vaz Kerges Bueno; Ludhmila Abrahão Hajjar; Aurora Felice Castro Issa; Felix José Alvarez Ramires; Otavio Rizzi Coelho Filho; André Schmidt; Ibraim Masciarelli Francisco Pinto; Carlos Eduardo Rochitte; Marcelo Luiz Campos Vieira; Cláudio Tinoco Mesquita; Celso Dario Ramos; José Soares-Junior; Minna Moreira Dias Romano; Wilson Mathias Junior; Marcelo Iório Garcia Junior; Marcelo Westerlund Montera; Marcelo Dantas Tavares de Melo; Sandra Marques E Silva; Pedro Manoel Marques Garibaldi; Aristóteles Comte de Alencar Neto; Renato Delascio Lopes; Diane Xavier de Ávila; Denizar Viana; José Francisco Kerr Saraiva; Manoel Fernandes Canesin; Glaucia Maria Moraes de Oliveira; Evandro Tinoco Mesquita
Journal:  Arq Bras Cardiol       Date:  2021-09       Impact factor: 2.000

Review 2.  Clinical management of amyloid cardiomyopathy.

Authors:  Morris M Kim; Clinton M Kolseth; Dayna Carlson; Ahmad Masri
Journal:  Heart Fail Rev       Date:  2021-09-01       Impact factor: 4.654

3.  New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact.

Authors:  Eve Cariou; Kevin Sanchis; Khailène Rguez; Virginie Blanchard; Stephanie Cazalbou; Pauline Fournier; Antoine Huart; Murielle Roussel; Pascal Cintas; Michel Galinier; Didier Carrié; Philippe Maury; Yoan Lavie-Badie; Olivier Lairez
Journal:  Front Cardiovasc Med       Date:  2021-11-30

Review 4.  Anticoagulation in cardiomyopathy: unravelling the hidden threat and challenging the threat individually.

Authors:  Xiaogang Zhu; Zhenhua Wang; Markus W Ferrari; Katharina Ferrari-Kuehne; Javed Bulter; Xiuying Xu; Quanzhong Zhou; Yuhui Zhang; Jian Zhang
Journal:  ESC Heart Fail       Date:  2021-09-08

Review 5.  Cardiac Amyloidosis Treatment.

Authors:  Lily K Stern; Jignesh Patel
Journal:  Methodist Debakey Cardiovasc J       Date:  2022-03-14

Review 6.  ATTR Epidemiology, Genetics, and Prognostic Factors.

Authors:  Chukwuemeka A Obi; William C Mostertz; Jan M Griffin; Daniel P Judge
Journal:  Methodist Debakey Cardiovasc J       Date:  2022-03-14

7.  Systemic embolism in amyloid transthyretin cardiomyopathy.

Authors:  Silvia Vilches; Marianna Fontana; Esther Gonzalez-Lopez; Lindsey Mitrani; Giulia Saturi; Mary Renju; Jan M Griffin; Angelo Caponetti; Sahana Gnanasampanthan; Jeffeny De Los Santos; Christian Gagliardi; Adrian Rivas; Fernando Dominguez; Simone Longhi; Claudio Rapezzi; Mathew S Maurer; Julian Gillmore; Pablo Garcia-Pavia
Journal:  Eur J Heart Fail       Date:  2022-07-11       Impact factor: 17.349

Review 8.  Updates in Cardiac Amyloidosis Diagnosis and Treatment.

Authors:  Lily K Stern; Michelle M Kittleson
Journal:  Curr Oncol Rep       Date:  2021-03-16       Impact factor: 5.075

Review 9.  ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review.

Authors:  Jan M Griffin; Julie L Rosenthal; Justin L Grodin; Mathew S Maurer; Martha Grogan; Richard K Cheng
Journal:  JACC CardioOncol       Date:  2021-10-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.